• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

[2-(2-methoxyethoxy)pyridin-3-yl]methanamine (CAS No. 1016765-58-4): A Comprehensive Overview

[2-(2-methoxyethoxy)pyridin-3-yl]methanamine (CAS No. 1016765-58-4) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promising potential in various therapeutic applications. In this comprehensive overview, we will delve into the chemical properties, synthesis methods, biological activities, and recent research advancements associated with [2-(2-methoxyethoxy)pyridin-3-yl]methanamine.

Chemical Structure and Properties

[2-(2-methoxyethoxy)pyridin-3-yl]methanamine is a pyridine derivative with a methoxyethoxy substituent on the pyridine ring and an amino group attached to the methyl group. The molecular formula of this compound is C₉H₁₃N₂O₂, and its molecular weight is 183.21 g/mol. The presence of the methoxyethoxy group imparts unique solubility and stability properties to the molecule, making it suitable for various chemical and biological applications.

The compound exhibits good solubility in polar solvents such as water, ethanol, and dimethyl sulfoxide (DMSO). Its melting point is reported to be around 75°C, and it has a boiling point of approximately 260°C under standard atmospheric conditions. These physical properties make it amenable to various synthetic and analytical techniques.

Synthesis Methods

The synthesis of [2-(2-methoxyethoxy)pyridin-3-yl]methanamine can be achieved through several well-established methods. One common approach involves the reaction of 3-chloromethylpyridine hydrochloride with 2-methoxyethylamine in the presence of a base such as potassium carbonate or sodium hydride. This reaction typically proceeds via nucleophilic substitution, leading to the formation of the desired product.

An alternative synthetic route involves the use of palladium-catalyzed coupling reactions. For instance, the coupling of 3-bromopyridine with 2-methoxyethylamine using palladium(II) acetate and tri(o-tolyl)phosphine as catalysts can yield [2-(2-methoxyethoxy)pyridin-3-yl]methanamine with high efficiency and selectivity. This method is particularly advantageous for large-scale production due to its robustness and scalability.

Biological Activities and Therapeutic Potential

[2-(2-methoxyethoxy)pyridin-3-yl]methanamine has been extensively studied for its biological activities, particularly in the context of central nervous system (CNS) disorders. Recent research has shown that this compound exhibits potent neuroprotective effects by modulating various signaling pathways involved in neuronal survival and function.

In vitro studies have demonstrated that [2-(2-methoxyethoxy)pyridin-3-yl]methanamine can effectively inhibit the activity of monoamine oxidase (MAO), an enzyme responsible for the breakdown of neurotransmitters such as serotonin, dopamine, and norepinephrine. By reducing MAO activity, this compound may help alleviate symptoms associated with depression and anxiety disorders.

Furthermore, preclinical studies have indicated that [2-(2-methoxyethoxy)pyridin-3-yl]methanamine possesses anti-inflammatory properties. It has been shown to suppress the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which are implicated in various inflammatory diseases including rheumatoid arthritis and multiple sclerosis.

Clinical Trials and Future Prospects

The promising preclinical findings have led to increased interest in evaluating the therapeutic potential of [2-(2-methoxyethoxy)pyridin-3-yl]methanamine in clinical settings. Several phase I and II clinical trials are currently underway to assess its safety, tolerability, and efficacy in treating various neurological and inflammatory conditions.

Preliminary results from these trials have been encouraging, with patients showing significant improvements in symptom severity and quality of life. However, further research is needed to fully elucidate the mechanisms underlying its therapeutic effects and to optimize dosing regimens for different patient populations.

Conclusion

In conclusion, [2-(2-methoxyethoxy)pyridin-3-yl]methanamine (CAS No. 1016765-58-4) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure confers favorable physical properties that make it suitable for various synthetic and analytical techniques. Moreover, its biological activities, including neuroprotective and anti-inflammatory effects, position it as a potential therapeutic agent for treating neurological and inflammatory disorders.

Ongoing research efforts aim to further explore the mechanisms underlying its biological activities and to evaluate its clinical efficacy in larger patient populations. As our understanding of this compound continues to evolve, it holds great promise for advancing the treatment options available for patients suffering from these debilitating conditions.

• 851773-43-8((2-Ethoxypyridin-3-yl)methanamine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)